-transparent.png){kind=logo}
DNA-binding proteins were isolated from Yoshida ascites tumor fluid by chromatography on DNA-cellulose. This fraction represents 1-2% of the total ascites protein. Most of the DNA-binding proteins will bind to phosphocellulose as well. The proteins migrate by agarose gel electrophoresis at pH 8.6 as alpha and beta globulins. Quantitative immunoelectrophoresis revealed the presence of 12-18 proteins. SDS-polyacrylamide electrophoresis indicated molecular weights ranging from 3-10(4) to 10(6). Seven of the proteins were identified by specific immunoprecipitation as beta1-Eglobulin, beta2-glycoprotein I, fibrinogen split product E (fibrinogen E), coagulation factor XIII (factor XIII), alpha2-macroglobulin, IgG and IgM. Alpha1-antichymotrypsin might also be represented. In nuclear extracts of the tumor cells only factor XIII was present. With the exception of fibrinogen E and P5 all recognized DNA-binding proteins are present in normal rat plasma. With increasing tumor age the concentration of fibrinogen E, factor XIII, P5 and IgM increased both in ascites fluid and in plasma, while the concentration of other DNA-binding-proteins decreased or remained constant. Evidence is presented that the DNA- and phosphocellulose binding ascites protein fraction inhibit tumor cell growth. No inhibition was induced by corresponding protein fractions isolated from normal rat plasma.
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
August 1983,
Experimental cell research,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
January 1989,
Anticancer research,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
August 1983,
Life sciences,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
July 1984,
Cell biology international reports,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
October 1975,
Chemico-biological interactions,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
July 1983,
Pharmacological research communications,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
October 1972,
Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
January 1969,
Zeitschrift fur Krebsforschung,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
January 1962,
Acta - Unio Internationalis Contra Cancrum,
J Kroll, and
J K Larsen, and
H Loft, and
M Ezban, and
K Wallevik, and
M Faber
January 1974,
Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology,
